Propofol Sensor for Anesthesia
Real-time propofol monitoring during anesthesia
Pre-clinicalActive
Key Facts
Indication
Real-time propofol monitoring during anesthesia
Phase
Pre-clinical
Status
Active
Company
About Infusense
Infusense is developing a portable electrochemical biosensor platform designed for the rapid and precise quantification of specific drugs, including anesthetics like propofol and illicit substances like fentanyl. The technology, supported by peer-reviewed research and significant non-dilutive grant funding, demonstrates nanomolar detection limits and analysis times of just minutes. The company is in a pre-revenue, R&D-focused stage, targeting applications in controlled anesthesia delivery and substance toxicity testing, with a clear path toward regulatory submission and commercialization.
View full company profile